Replies to post #202990 on Biotech Values

[DewDiligence]

MRK has GT1B approval in EU...

Yes, of course; the salient points are that Viekira doesn't require ribavirin for GT1b patients (as it does for GT1a) and that Viekira has somewhat better efficacy than Zepatier.